As the future of MoviePass remains in doubt, here are several alternatives for moviegoers to consider.
The MoviePass rival Sinemia filed for bankruptcy and said it was shutting down US operations. It also said it was under investigation by the FTC.
MoviePass competitor Sinemia has shut down in the US, the company said on Thursday.
MoviePass competitor Sinemia added a clause to its terms of service to try and prevent its subscribers from suing after being hit with class-action.
Movie-ticket subscription company Sinemia is launching a 'unlimited plan' for $14.99, days after MoviePass announced it was bringing back its own.
Sinemia said since the beginning of March, it's removed about 3 percent of its accounts due to "misuse or fraudulent activity."
YouTube video shows Sinemia member in good standing trying to book a ticket to "Captain Marvel," at which point his account is terminated.
Sinemia confirmed to Business Insider that its customer service wouldn't be sharing more details with terminated subscribers.
Welcome to the Advertising and Media Insider newsletter
MoviePass competitor Sinemia is asking some subscribers to tip it, suggesting $1, $2, or $5.
The MoviePass competitor Sinemia has been terminating subscribers' accounts over the past few days.
An amended complaint in a class-action lawsuit against MoviePass competitor Sinemia was filed this week over a new fee.
20 Sinemia subscribers contacted Business Insider to complain about a "misuse fee," which they said had been unfairly applied.
Sinemia customers received an email on Thursday informing them they need to send in two forms of identification to continue using their accounts.
Sinemia Enterprise launched in October and the interest from theaters to start their own movie ticket subscription plans has been strong.
Here are all the ways MoviePass competitor Sinemia can charge you fees.
MoviePass competitor Sinemia is re-introducing debit cards that allow customers to bypass its per-movie fees (though the card itself costs $14.99).
Movie-ticket subscription services are popular, but MoviePass and Sinemia have 'F' ratings from the Better Business Bureau are subject of lawsuits.
A law firm has filed a class action lawsuit in Delaware on behalf of two plaintiffs, alleging that MoviePass competitor Sinemia “essentially became a bait-and-switch scheme.”
Sinemia is an affordable MoviePass alternative that has comparable features and pricing, but it has flaws as well